Your browser doesn't support javascript.
loading
Prevalence of Publicly Available Expanded Access Policies.
Jung, Emily; Zettler, Patricia J; Kesselheim, Aaron S.
Affiliation
  • Jung E; Faculty of Arts and Sciences, Harvard University, Cambridge, Massachusetts, USA.
  • Zettler PJ; Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Kesselheim AS; Center for Law, Health & Society, Georgia State University College of Law, Atlanta, Georgia, USA.
Clin Pharmacol Ther ; 104(5): 1016-1021, 2018 11.
Article in En | MEDLINE | ID: mdl-29271014
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: United States Food and Drug Administration / Access to Information / Drug Industry / Compassionate Use Trials / Health Policy / Health Services Accessibility Type of study: Guideline / Prevalence_studies / Prognostic_studies / Risk_factors_studies Aspects: Determinantes_sociais_saude Limits: Humans Country/Region as subject: America do norte Language: En Journal: Clin Pharmacol Ther Year: 2018 Document type: Article Affiliation country: United States Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: United States Food and Drug Administration / Access to Information / Drug Industry / Compassionate Use Trials / Health Policy / Health Services Accessibility Type of study: Guideline / Prevalence_studies / Prognostic_studies / Risk_factors_studies Aspects: Determinantes_sociais_saude Limits: Humans Country/Region as subject: America do norte Language: En Journal: Clin Pharmacol Ther Year: 2018 Document type: Article Affiliation country: United States Country of publication: United States